Predicting risk of drug-resistant organisms in pneumonia: Moving beyond the HCAP model

Respiratory Medicine

Volumn 109, Issue 1, 2015, Pages 1-10

  Webb, Brandon J ^a,b   Dascomb, Kristin ^a,b   Stenehjem, Edward ^a,b   Dean, Nathan ^c  

^a UNIVERSITY OF UTAH   (United States)

^b INTERMOUNTAIN MEDICAL CENTER   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Antibiotic; Antimicrobial stewardship; Community acquired; Drug resistance; Healthcare associated; Pneumonia

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ENTEROBACTERIACEAE; HAEMOPHILUS INFLUENZAE; HUMAN; LEGIONELLA PNEUMOPHILA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORAXELLA CATARRHALIS; MYCOPLASMA PNEUMONIAE; NONHUMAN; PNEUMONIA; PREVALENCE; PSEUDOMONAS AERUGINOSA; REVIEW; RISK FACTOR; STREPTOCOCCUS PNEUMONIAE; BIOLOGICAL MODEL; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; MICROBIOLOGY; PNEUMONIA, BACTERIAL; PROCEDURES; RISK ASSESSMENT;

ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MODELS, BIOLOGICAL; PNEUMONIA, BACTERIAL; RISK ASSESSMENT; RISK FACTORS;

EID: 84919725929     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2014.10.017     Document Type: Review

References (56)

1. V.C.O.M. Buie, C.J. DeFrances, and A. Golosinskiy National hospital discharge survey: 2006 summary. National Center for health statistics Vital Health Stat 13 168 2010
2. M. Heron, D.L. Hoyert, S.L. Murphy, J. Xu, K.D. Kochanek, and B. Tejada-Vera Deaths: final data for 2006. National vital statistics reports: from the Centers for Disease Control and Prevention, National Center for Health Statistics Natl Vital Stat Syst 57 14 2009 1 134
3. M.S. Niederman, J.B. Bass Jr., G.D. Campbell, A.M. Fein, R.F. Grossman, and L.A. Mandell Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association Am Rev Respir Dis 148 5 1993 1418 1426
4. C. McCabe, C. Kirchner, H. Zhang, J. Daley, and D.N. Fisman Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules Archives Intern Med 169 16 2009 1525 1531
5. J.D. Chalmers, C. Rother, W. Salih, and S. Ewig Healthcare-associated pneumonia does not accurately identify potentially resistant pathogens: a systematic review and meta-analysis Clin Infect Dis off Publ Infect Dis Soc Am 58 3 2014 330 339
6. L.S. Howard, M. Sillis, M.C. Pasteur, A.V. Kamath, and B.D. Harrison Microbiological profile of community-acquired pneumonia in adults over the last 20 years J Infect 50 2 2005 107 113
7. A.A. El-Solh, P. Sikka, F. Ramadan, and J. Davies Etiology of severe pneumonia in the very elderly Am J Respir Crit care Med 163 3 Pt 1 2001 645 651
8. M. Washio, S. Nishisaka, K. Kishikawa, K. Irie, A. Shinkawa, and T. Tashiro Incidence of methicillin-resistant Staphylococcus aureus (MRSA) isolation in a skilled nursing home: a third report on the risk factors for the occurrence of MRSA infection in the elderly J Epidemiol 6 2 1996 69 73
9. M.H. Kollef, A. Shorr, Y.P. Tabak, V. Gupta, L.Z. Liu, and R.S. Johannes Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia Chest 128 6 2005 3854 3862
10. S. Ewig, T. Welte, J. Chastre, and A. Torres Rethinking the concepts of community-acquired and health-care-associated pneumonia Lancet Infect Dis 10 4 2010 279 287
11. M.H. Kollef, G. Sherman, S. Ward, and V.J. Fraser Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients Chest 115 2 1999 462 474
12. J. Valles, J. Rello, A. Ochagavia, J. Garnacho, and M.A. Alcala Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival Chest 123 5 2003 1615 1624
13. G.E. Schramm, J.A. Johnson, J.A. Doherty, S.T. Micek, and M.H. Kollef Methicillin-resistant Staphylococcus aureus sterile-site infection: the importance of appropriate initial antimicrobial treatment Crit care Med 34 8 2006 2069 2074
14. S.T. Micek, A.E. Lloyd, D.J. Ritchie, R.M. Reichley, V.J. Fraser, and M.H. Kollef Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment Antimicrob Agents Chemother 49 4 2005 1306 1311
15. C.I. Kang, S.H. Kim, W.B. Park, K.D. Lee, H.B. Kim, and E.C. Kim Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome Antimicrob Agents Chemother 49 2 2005 760 766
16. Y. Shindo, S. Sato, E. Maruyama, T. Ohashi, M. Ogawa, and N. Hashimoto Health-care-associated pneumonia among hospitalized patients in a Japanese community hospital Chest 135 3 2009 633 640
17. M.D. Zilberberg, A.F. Shorr, S.T. Micek, S.H. Mody, and M.H. Kollef Antimicrobial therapy escalation and hospital mortality among patients with health-care-associated pneumonia: a single-center experience Chest 134 5 2008 963 968
18. ATS/IDSA Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia Am J Respir Crit care Med 171 4 2005 388 416
19. N.D. Friedman, K.S. Kaye, J.E. Stout, S.A. McGarry, S.L. Trivette, and J.P. Briggs Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections Ann Intern Med 137 10 2002 791 797
20. R.T. Attridge, C.R. Frei, M.I. Restrepo, K.A. Lawson, L. Ryan, and M.J. Pugh Guideline-concordant therapy and outcomes in healthcare-associated pneumonia Eur Respir J 38 4 2012 878 887
21. J.D. Chalmers, J.K. Taylor, A. Singanayagam, G.B. Fleming, A.R. Akram, and P. Mandal Epidemiology, antibiotic therapy, and clinical outcomes in health care-associated pneumonia: a UK cohort study Clin Infect Dis Off Publ Infect Dis Soc Am 53 2 2011 107 113
22. C. Grenier, J. Pepin, V. Nault, J. Howson, X. Fournier, and M.S. Poirier Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and community-acquired pneumonia J Antimicrob Chemother 66 7 2011 1617 1624
23. J.Y. Jung, M.S. Park, Y.S. Kim, B.H. Park, S.K. Kim, and J. Chang Healthcare-associated pneumonia among hospitalized patients in a Korean tertiary hospital BMC Infect Dis 11 2011 61
24. K.J. Madaras-Kelly, R.E. Remington, V.S. Fan, and K.L. Sloan Predicting antibiotic resistance to community-acquired pneumonia antibiotics in culture-positive patients with healthcare-associated pneumonia J Hosp Med Off Publ Soc Hosp Med 7 3 2012 195 202
25. A.F. Shorr, M.D. Zilberberg, R. Reichley, J. Kan, A. Hoban, and J. Hoffman Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department Clin Infect Dis 54 2 2012 193 198
26. M. Venditti, M. Falcone, S. Corrao, G. Licata, and P. Serra Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia Ann Intern Med 150 1 2009 19 26
27. B.J. Webb, B.S. Dangerfield, J.S. Pasha, N. Agrwal, and H.R. Vikram Guideline-concordant antibiotic therapy and clinical outcomes in healthcare-associated pneumonia Respir Med 106 11 2012 1606 1612
28. D.W. Bratzler, A. Ma, and W. Nsa Initial antibiotic selection and patient outcomes: observations from the National Pneumonia Project Clin Infect Dis Off Publ Infect Dis Soc Am 47 Suppl. 3 2008 S193 S201
29. N.C. Dean, K.A. Bateman, S.M. Donnelly, M.P. Silver, G.L. Snow, and D. Hale Improved clinical outcomes with utilization of a community-acquired pneumonia guideline Chest 130 3 2006 794 799
30. M.P. Schreiber, C.M. Chan, and A.F. Shorr Resistant pathogens in nonnosocomial pneumonia and respiratory failure: is it time to refine the definition of health-care-associated pneumonia? Chest 137 6 2010 1283 1288
31. A.F. Shorr, M.D. Zilberberg, S.T. Micek, and M.H. Kollef Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care-associated pneumonia Archives Intern Med 168 20 2008 2205 2210
32. J.I. Chen, L.N. Slater, G. Kurdgelashvili, K.O. Husain, and C.A. Gentry Outcomes of health care-associated pneumonia empirically treated with guideline-concordant regimens versus community-acquired pneumonia guideline-concordant regimens for patients admitted to acute care wards from home Ann Pharmacother 47 1 2013 9 19
33. A.X. Troitino, J. Porhomayon, and A.A. El-Solh Guideline-concordant antimicrobial therapy for healthcare-associated pneumonia: a systematic review and meta-analysis Lung 191 3 2013 229 237
34. S. Aliberti, C. Cilloniz, J.D. Chalmers, A.M. Zanaboni, R. Cosentini, and P. Tarsia Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective Thorax 68 11 2013 997 999
35. T. Maruyama, T. Fujisawa, M. Okuno, H. Toyoshima, K. Tsutsui, and H. Maeda A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy Clin Infect Dis Off Publ Infect Dis Soc Am 57 10 2013 1373 1383
36. S.C. Park, E.Y. Kim, Y.A. Kang, M.S. Park, Y.S. Kim, and S.K. Kim Validation of a scoring tool to predict drug-resistant pathogens in hospitalised pneumonia patients Int J Tuberc Lung Dis 17 5 2013 704 709
37. Y. Shindo, R. Ito, D. Kobayashi, M. Ando, M. Ichikawa, and A. Shiraki Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia Am J Respir Crit care Med 188 8 2013 985 995
38. J. Rello, M. Lujan, M. Gallego, J. Valles, Y. Belmonte, and D. Fontanals Why mortality is increased in health-care-associated pneumonia: lessons from pneumococcal bacteremic pneumonia Chest 137 5 2010 1138 1144
39. M.N. Jeffres, W. Isakow, J.A. Doherty, S.T. Micek, and M.H. Kollef A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia Clin Ther 29 6 2007 1107 1115
40. L.D. Burgess, and R.H. Drew Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam Pharmacotherapy 34 7 2014 670 676
41. D.M. Gomes, C. Smotherman, A. Birch, L. Dupree, B.J. Della Vecchia, and D.F. Kraemer Comparison of acute kidney injury during treatment with vancomycin in combination with piperacillin-tazobactam or cefepime Pharmacotherapy 34 7 2014 662 669
42. J.D. Chalmers, M. Al-Khairalla, P.M. Short, T.C. Fardon, and J.H. Winter Proposed changes to management of lower respiratory tract infections in response to the Clostridium difficile epidemic J Antimicrob Chemother 65 4 2010 608 618
43. C. Costelloe, C. Metcalfe, A. Lovering, D. Mant, and A.D. Hay Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis BMJ 340 2010 c2096
44. A.E. Gross, T.C. Van Schooneveld, K.M. Olsen, M.E. Rupp, T.H. Bui, and E. Forsung Epidemiology and predictors of multidrug-resistant community-acquired and health care-associated pneumonia Antimicrob Agents Chemother 58 9 2014 5262 5268
45. A.F. Shorr, D.E. Myers, D.B. Huang, B.H. Nathanson, M.F. Emons, and M.H. Kollef A risk score for identifying methicillin-resistant Staphylococcus aureus in patients presenting to the hospital with pneumonia BMC Infect Dis 13 1 2013 268
46. D.A. Wooten, and L.G. Winston Risk factors for methicillin-resistant Staphylococcus aureus in patients with community-onset and hospital-onset pneumonia Respir Med 107 8 2013 1266 1270
47. S. Aliberti, M. Di Pasquale, A.M. Zanaboni, R. Cosentini, A.M. Brambilla, and S. Seghezzi Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia Clin Infect Dis Off Publ Infect Dis Soc Am 54 4 2012 470 478
48. J. Fisch, B. Lansing, L. Wang, K. Symons, K. Cherian, and S. McNamara New acquisition of antibiotic-resistant organisms in skilled nursing facilities J Clin Microbiol 50 5 2012 1698 1703
49. P.M. Filius, I.C. Gyssens, I.M. Kershof, P.J. Roovers, A. Ott, and A.G. Vulto Colonization and resistance dynamics of gram-negative bacteria in patients during and after hospitalization Antimicrob Agents Chemother 49 7 2005 2879 2886
50. S.C. Park, Y.A. Kang, B.H. Park, E.Y. Kim, M.S. Park, and Y.S. Kim Poor prediction of potentially drug-resistant pathogens using current criteria of health care-associated pneumonia Respir Med 106 9 2012 1311 1319
51. A.A. El Solh, C. Pietrantoni, A. Bhat, M. Bhora, and E. Berbary Indicators of potentially drug-resistant bacteria in severe nursing home-acquired pneumonia Clin Infect Dis Off Publ Infect Dis Soc Am 39 4 2004 474 480
52. N.C. Dean, B.E. Jones, J.P. Ferraro, C.G. Vines, and P.J. Haug Performance and utilization of an emergency department electronic screening tool for pneumonia JAMA Intern Med 173 8 2013 699 701
53. V. Brito, and M.S. Niederman Healthcare-associated pneumonia is a heterogeneous disease, and all patients do not need the same broad-spectrum antibiotic therapy as complex nosocomial pneumonia Curr Opin Infect Dis 22 3 2009 316 325
54. B. Dangerfield, A. Chung, B. Webb, and M.T. Seville Predictive value of methicillin-resistant Staphylococcus aureus (MRSA) nasal swab PCR assay for MRSA pneumonia Antimicrob Agents Chemother 58 2 2014 859 864
55. M.I. Mustafa, F. Al-Marzooq, S.H. How, Y.C. Kuan, and T.H. Ng The use of multiplex real-time PCR improves the detection of the bacterial etiology of community acquired pneumonia Trop Biomed 28 3 2011 531 544
56. S. Aliberti, A.M. Zanaboni, and F. Blasi Pneumonia in the community caused by multidrug-resistant organisms: keep working on probabilistic scores Clin Infect Dis Off Publ Infect Dis Soc Am 54 10 2012 1519 1520 [author reply 21-2]